Cargando…

Genetic lesions within the 3a gene of SARS-CoV

A series of frameshift mutations within the 3a gene has been observed in culture-derived severe acute respiratory syndrome coronavirus (SARS-CoV). We report here that viral RNA from clinical samples obtained from SARS-CoV infected patients also contains a heterogeneous population of wild-type and mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Timothy HP, Barkham, Timothy, Fielding, Burtram C, Chou, Chih-Fong, Shen, Shuo, Lim, Seng Gee, Hong, Wanjin, Tan, Yee-Joo
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1183252/ https://www.ncbi.nlm.nih.gov/pubmed/15963240 http://dx.doi.org/10.1186/1743-422X-2-51

Ejemplares similares

A novel cell-based binding assay system reconstituting interaction between SARS-CoV S protein and its cellular receptor
por: Chou, Chih-Fong, et al.
Publicado: (2005)

Over-expression of severe acute respiratory syndrome coronavirus 3b protein induces both apoptosis and necrosis in Vero E6 cells
por: Khan, Sehaam, et al.
Publicado: (2006)

Severe acute respiratory syndrome coronavirus protein 7a interacts with hSGT()
por: Fielding, Burtram C., et al.
Publicado: (2006)

ACE2 orthologues in non-mammalian vertebrates (Danio, Gallus, Fugu, Tetraodon and Xenopus)
por: Chou, Chih-Fong, et al.
Publicado: (2006)

The use of hepatitis C virus NS3/4A and secreted alkaline phosphatase to quantitate cell–cell membrane fusion mediated by severe acute respiratory syndrome coronavirus S protein and the receptor angiotensin-converting enzyme 2
por: Chou, Chih-Fong, et al.
Publicado: (2007)

Characterization of viral proteins encoded by the SARS-coronavirus genome
por: Tan, Yee-Joo, et al.
Publicado: (2005)

Understanding the accessory viral proteins unique to the severe acute respiratory syndrome (SARS) coronavirus
por: Tan, Yee-Joo, et al.
Publicado: (2006)

The human severe acute respiratory syndrome coronavirus (SARS-CoV) 8b protein is distinct from its counterpart in animal SARS-CoV and down-regulates the expression of the envelope protein in infected cells
por: Keng, Choong-Tat, et al.
Publicado: (2006)

Editorial: Human coronavirus research: 20 years since the SARS-CoV outbreak
por: Fielding, Burtram C.
Publicado: (2022)

Expression, Glycosylation, and Modification of the Spike (S) Glycoprotein of SARS CoV
por: Shen, Shuo, et al.
Publicado: (2007)

The severe acute respiratory syndrome coronavirus 3a is a novel structural protein
por: Shen, Shuo, et al.
Publicado: (2005)

Leptin Deficiency, Caused by Malnutrition, Makes You Susceptible to SARS-CoV-2 Infection but Could Offer Protection from Severe COVID-19
por: Schoeman, Dewald, et al.
Publicado: (2021)

MERS-CoV: Understanding the Latest Human Coronavirus Threat
por: Chafekar, Aasiyah, et al.
Publicado: (2018)

Phosphoproteomics Unravel HBV Triggered Rewiring of Host Phosphosignaling Events
por: Lim, ZiJie, et al.
Publicado: (2022)

The Role of Severe Acute Respiratory Syndrome (SARS)-Coronavirus Accessory Proteins in Virus Pathogenesis
por: McBride, Ruth, et al.
Publicado: (2012)

Human coronavirus NL63: a clinically important virus?
por: Fielding, Burtram C
Publicado: (2011)

Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2)
por: Egieyeh, Samuel, et al.
Publicado: (2021)

Influenza disease burden in adults by subtypes following the initial epidemic of pandemic H1N1 in Singapore
por: Win, Mar K., et al.
Publicado: (2011)

The nonstructural protein 8 (nsp8) of the SARS coronavirus interacts with its ORF6 accessory protein
por: Kumar, Purnima, et al.
Publicado: (2007)

Amino acids 15–28 in the ectodomain of SARS coronavirus 3a protein induces neutralizing antibodies
por: Åkerström, Sara, et al.
Publicado: (2006)

The p7 protein of the hepatitis C virus induces cell death differently from the influenza A virus viroporin M2
por: Aweya, Jude Juventus, et al.
Publicado: (2013)

Coronavirus envelope protein: current knowledge
por: Schoeman, Dewald, et al.
Publicado: (2019)

HIV and Human Coronavirus Coinfections: A Historical Perspective
por: Makoti, Palesa, et al.
Publicado: (2020)

Is There a Link Between the Pathogenic Human Coronavirus Envelope Protein and Immunopathology? A Review of the Literature
por: Schoeman, Dewald, et al.
Publicado: (2020)

Human Coronaviruses: Counteracting the Damage by Storm
por: Schoeman, Dewald, et al.
Publicado: (2021)

Understanding Human Coronavirus HCoV-NL63
por: Abdul-Rasool, Sahar, et al.
Publicado: (2010)

Human coronavirus OC43 3CL protease and the potential of ML188 as a broad-spectrum lead compound: Homology modelling and molecular dynamic studies
por: Berry, Michael, et al.
Publicado: (2015)

Practical Considerations in Virtual Screening and Molecular Docking
por: Berry, Michael, et al.
Publicado: (2015)

Importation of SARS-CoV-2 infection leads to major COVID-19 epidemic in Taiwan
por: Lin, Chih-Yen, et al.
Publicado: (2020)

Identification of New Respiratory Viruses in the New Millennium
por: Berry, Michael, et al.
Publicado: (2015)

Potential Broad Spectrum Inhibitors of the Coronavirus 3CL(pro): A Virtual Screening and Structure-Based Drug Design Study
por: Berry, Michael, et al.
Publicado: (2015)

Coronaviruses
por: Schoeman, Dewald, et al.
Publicado: (2022)

The Flexible, Extended Coil of the PDZ-Binding Motif of the Three Deadly Human Coronavirus E Proteins Plays a Role in Pathogenicity
por: Schoeman, Dewald, et al.
Publicado: (2022)

SARS‐CoV‐2 viral spike G614 mutation exhibits higher case fatality rate
por: Becerra‐Flores, Manuel, et al.
Publicado: (2020)

Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2
por: Zheng, Zhiqiang, et al.
Publicado: (2020)

An Otorhinolaryngology Perspective Into a Hospital COVID-19 Cluster
por: Tan, Jian Li, et al.
Publicado: (2021)

Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant
por: Lee, Cheryl Yi‐Pin, et al.
Publicado: (2021)

Differential heterologous neutralisation profile against strains within DENV-3 genotype II
por: Tan, K.K., et al.
Publicado: (2021)

Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery
por: Mohebbi, Alireza, et al.
Publicado: (2021)

A Study of Analytical and Clinical Sensitivity of Aptima SARS-CoV-2 Assay (Hologic) and Proposals of Complementary Tests for SARS-CoV-2 Detection in Low Viral Load Specimens
por: La, My-Van, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_18208087c7g8u9t21kamq3rq4m